Immunetics MycoDx | GenomeWeb

Immunetics MycoDx

Feb 23, 2016

Immunetics has launched the MycoDx assay, a multiplex molecular assay that can identify 21 fungal pathogens in a whole blood sample, including Candida, Aspergillus, Cryptococcus, Coccidioides, Fusarium and other species. Other fungal targets are also in development.

The new test — which Immunetics will offer through its US clinical reference laboratory service — does not require a culturing step, reducing assay turnaround time to about eight hours. The company said its development team is also working to transfer the assay into a user friendly microarray format for worldwide distribution.

More Like This

Jan 18, 2017

Cambridge Isotope Laboratories Mouse Express NeuCode

Cambridge Isotope Laboratories has launched Mouse Express NeuCode, a mouse feed with various combinations of labeled Lys isotopologues for MS proteomics studies. The product will increase the multiplexing potential for traditional SILAC quantitative experiments involving neuron encoding. It uses isotopologues of lysine for multiplexed relative quantification of proteins by high-resolution MS. NeuCode also drastically cuts down on labeling time compared to SILAM and allows detection of a greater number of peptides than SILAC, the company said. The product is available in one week or three week quantities, and each kit contains enough feed for three mice.

Jan 11, 2017

Celmatix Fertilome

Celmatix has launched Fertilome, a genetic screen that reveals how a woman's DNA may influence her reproductive health. The test analyzes a patient's blood samples for genetic factors associated with the most common reproductive conditions that can lead to fertility difficulties in women, including endometriosis, polycystic ovarian syndrome, and primary ovarian insufficiency. Fertilome is available through physicians.

Jan 11, 2017

Dolomite Bio Injection Valve and Sample Loop

Dolomite Bio has launched a Injection Valve and Sample Loop for single cell RNA sequencing workflows. The product is a complete four-way valve module which allow barcoded mRNA capture beads in lysis buffer to efficiently flow through the RNA-Seq chip. Its design and simple microfluidic connections enable seamless switching between the injection of the bead suspension and pumping of a driving fluid. This produces minimal dead volume and bead wastage compared to traditional syringe pump methods, the company said.

Jan 11, 2017

Bioline EPIK MiRNA Select Assays

Meridian Bioscience subsidiary Bioline has launched a full range of EPIK miRNA Select assays. The recent release includes all of the organisms listed on the miRBase release 21, which increases the number of EPIK miRNA assays to over 27,000. Each assay was designed in collaboration with MiRXES in silico using thermodynamics-based algorithms. They also include miRNA specific reverse transcriptase primers and hemi-nested real-time PCR primers along with Bioline reverse transcriptase, SensiSmart with SYBR Green, and optimized buffers.

Jan 09, 2017

Cynvenio ClearID Breast Cancer Test

Cynvenio Biosystems released its updated ClearID Breast Cancer blood test, which leverages a custom-developed NGS panel of 27 genes known to be altered in breast cancer. The updated test identifies circulating tumor cell burden and detects emerging genetic alterations that are associated with therapy resistance. The assay has been optimized to monitor patients with advanced breast cancer during the start of therapy and at regular intervals following treatment. 

Jan 09, 2017

Pacific Biosciences Sequel Chemistry and Software Update

Pacific Biosciences has launched a new chemistry, V2, and new software, V4, for its Sequel sequencing system that will be available on Jan. 23. The release also includes a new version of the consumable SMRT cells. The updates improve the system's ability to support applications such as structural variant detection and targeted sequencing for tasks such as metagenomics, minor variant detection, and isoform sequencing. The mean read length is now 10 to 18 kilobases, with half the data in reads larger than 20 kilobases. Throughput is now 5 to 8 gigabases, depending on sample type and sample prep method used. The system is now also capable of loading 80-kilobase sequencing libraries. The new software includes updates to the base-calling algorithm that increase accuracy and new features to the system software to support clinical research applications.

Jan 05, 2017

Core Informatics Sanger Sequencing and Microarray Genotyping Apps

Core Informatics has released two applications for its Platform for Science that are designed to help researchers execute microarray genotyping and Sanger sequencing workflows. The company's Sanger sequencing application provides data management tools for small-scale projects in both regulated and non-regulated laboratory environments. It includes capabilities for analyzing long reads as well as for validating next-generation sequencing results. The microarray genotyping application lets users track samples as well as capture and manage data as part of large-scale genotyping projects.

Jan 05, 2017

Baylor Genetics PreSeek for Prenatal Multi-Gene Sequencing Screen

Baylor Genetics has launched PreSeek, a clinical non-invasive prenatal multi-gene sequencing screen. The test requires blood and/or saliva samples from each parent, then sequences cell-free fetal DNA for de novo disease-causing variants associated with select single-gene conditions affecting the skeletal, cardiac, and neurological systems. It is complementary to traditional prenatal screening tests, the company said.

Jan 03, 2017

Fluidigm C1 Medium-Cell High-Throughput IFC

Fluidigm has released its new high-throughput integrated fluidic circuit (HT IFC) for isolating medium-sized single cells using the firm's C1 system for mRNA sequencing. The device captures up to 800 single cells, between 10 and 17 micrometers, at higher capture efficiency and comes with live, on-IFC imaging for viability and phenotypic analysis. The firm added that the new chip enables scaling of cell atlas and lineage study applications.

Dec 28, 2016

Zymo Research Sample Collection Devices

Zymo Research has launched five new sample collection devices featuring the company's DNA/RNA Shield storage reagent, which preserves the integrity and expression profiles of samples including cells, tissues, blood, plasma, serum, saliva, urine, and feces at ambient temperatures for extended periods.

The new collection devices are: DNA/RNA Shield Swab Collection Tube, ideal for mouth, nose, throat, and environmental samples; DNA/RNA Shield Blood Collection Tube, ideal for gene expression analysis, miRNA analysis, and blood-borne pathogen detection; DNA/RNA Shield Fecal Collection Tube, which can be used for miRNA analysis, pathogen detection, gene expression, and microbiomic analysis; and DNA/RNA Shield Lysis Tubes for tissues and microbes.

Dec 22, 2016

GenBank 217

GenBank 217 is now available via ftp from the National Center for Biotechnology Information. Uncompressed flatfiles in this release require 809 gigabytes for sequence files only. The ASN.1 data requires approximately 671 GB.

Dec 21, 2016

Invitae Pediatric, Neurological, and Rare Disease Test Expansion

Invitae has launched 42 new and 19 expanded genetic test panels as part of the company's pediatric, neurological, and rare disease offerings. The new offerings allow clinicians to gain information on 183 genes with clinical and diagnostic significance. The expanded offerings include comprehensive testing for epilepsy and epilepsy-related disorders; an expansion of panel testing for developmental disorders, overgrowth syndromes, skeletal disorders, and RASopathies/Noonan spectrum disorders; incorporation of the latest genetic findings for ciliopathies; and consolidation of clinical areas, enabling customers to order a broader set of tests that are relevant for the patient.

Dec 21, 2016

Fluidigm Medium-Cell HT IFC

Fluidigm has launched its medium cell, high-throughput integrated fluidic circuit to isolate single cells for mRNA sequencing analysis. The circuit captures up to 800 medium-size cells with higher single-cell capture efficiency, which enables researchers to scale cell lineage studies using Fluidigm's C1 system, the company said. The new workflow supports the identification of cell subpopulations present at low abundance across a wide range of cell types, including cancer and stem cells.

Dec 21, 2016

Natera Constellation Update

Natera has launched an update to Constellation, its cloud-based software platform. The update includes the addition of microdeletion testing capability, which allows researchers to test for chromosomal abnormalities in the fetus. This testing includes the company's Panorama prenatal test which can screen for a number of chromosomal abnormalities in a developing fetus, including 22q11.2 deletion syndrome.

Dec 21, 2016

Cellecta Single-Module CRISPR Human Genome-Wide 80K Knockout Library

Cellecta has launched the single-module CRISPR Human Genome-Wide 80K Knockout library. The new library includes 4 guide RNAs per gene and is half the size of the company's current three-module CRISPR 150K Human Genome-Wide Knockout Library. The reduced library size enables researcher to study how cells respond to the disruption of each gene across the entire human genome in a single screening experiment. This aids the researchers ability to identify genetic elements that are functionally important in biological responses and identify new therapeutic targets.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.